Skip to Main content Skip to Navigation
Journal articles

Proteomics and the blood–brain barrier: how recent findings help drug development

Abstract : The drug discovery and development processes are divided into different stages separated by milestones to indicate that significant progress has been made and that certain criteria for target validation, hits, leads and candidate drugs have been met. Proteomics is a promising approach for the identification of protein targets and biochemical pathways involved in disease process and thus plays an important role in several stages of the drug development. The blood-brain barrier is considered as a major bottleneck when trying to target new compounds to treat neurodegenerative diseases. Based on the survey of recent findings and with a projection on expected improvements, this report attempt to address how proteomics participates in drug development.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-artois.archives-ouvertes.fr/hal-02510297
Contributor : Virginie Justin-Labonne <>
Submitted on : Tuesday, March 17, 2020 - 4:18:44 PM
Last modification on : Wednesday, March 25, 2020 - 3:43:17 PM

Identifiers

Collections

Citation

Yannis Karamanos, Gwënaël Pottiez. Proteomics and the blood–brain barrier: how recent findings help drug development. Expert Review of Proteomics, Taylor & Francis, 2016, 13 (3), pp.251-258. ⟨10.1586/14789450.2016.1143780⟩. ⟨hal-02510297⟩

Share

Metrics

Record views

284